These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Differences in immunoglobulin preparations and outcome of Kawasaki disease. Yavuz H; Ozel A J Pediatr; 1996 May; 128(5 Pt 1):719-20. PubMed ID: 8627453 [No Abstract] [Full Text] [Related]
25. Evidence-based management of Kawasaki disease in the emergency department. Seaton KK; Kharbanda A Pediatr Emerg Med Pract; 2015 Jan; 12(1):1-20; quiz 21. PubMed ID: 25693305 [TBL] [Abstract][Full Text] [Related]
26. Kawasaki disease: part II. Complications and treatment. Bayers S; Shulman ST; Paller AS J Am Acad Dermatol; 2013 Oct; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380 [TBL] [Abstract][Full Text] [Related]
27. Kawasaki disease in Calcutta. Paul DK; Gupta A; Lahiri M Indian Pediatr; 2000 Nov; 37(11):1264-5. PubMed ID: 11086312 [No Abstract] [Full Text] [Related]
28. [New aspects of therapy in Kawasaki disease]. Keren G; Ballin A Harefuah; 1994 Jun; 126(11):667-71. PubMed ID: 7927003 [No Abstract] [Full Text] [Related]
29. Mechanisms of immunoglobulin action: observations on Kawasaki syndrome and RSV prophylaxis. Meissner HC; Schlievert PM; Leung DY Immunol Rev; 1994 Jun; 139():109-23. PubMed ID: 7927408 [No Abstract] [Full Text] [Related]
30. Treatment of a Jehovah's Witness with immune globulin: case of a child with Kawasaki syndrome. Roy-Bornstein C; Sagor LD; Roberts KB Pediatrics; 1994 Jul; 94(1):112-3. PubMed ID: 8008516 [No Abstract] [Full Text] [Related]
31. Intravenous Immunoglobulin for the Treatment of Kawasaki Disease. Shulman ST Pediatr Ann; 2017 Jan; 46(1):e25-e28. PubMed ID: 28079915 [TBL] [Abstract][Full Text] [Related]
32. Kawasaki disease. Bavdekar SB; Vaswani LK; Shalini H; Chandu KV; Gaikwad R; Kamat JR J Indian Med Assoc; 1998 Aug; 96(8):257-8. PubMed ID: 9830299 [No Abstract] [Full Text] [Related]
33. Positive hepatitis serologies with treatment for Kawasaki syndrome. Borowitz SM Arch Dis Child; 1993 Jan; 68(1):151. PubMed ID: 8435007 [No Abstract] [Full Text] [Related]
34. Corticosteroids for the Treatment of Kawasaki Disease in Children. Beck RA; Spiva S Am Fam Physician; 2023 Jan; 107(1):20-21. PubMed ID: 36689961 [No Abstract] [Full Text] [Related]
35. Pharmacological therapy for patients with Kawasaki disease. Williams RV; Minich LL; Tani LY Paediatr Drugs; 2001; 3(9):649-60. PubMed ID: 11688596 [TBL] [Abstract][Full Text] [Related]
36. Orange-brown chromonychia: A valid sign in Kawasaki disease in children of different ethnicities. Yamazaki-Nakashimada MA; Deguchi K; Gámez-González B; Ulloa-Gutierrez R; Hamada H Int J Rheum Dis; 2019 Jun; 22(6):1160-1161. PubMed ID: 31044543 [No Abstract] [Full Text] [Related]
37. Adult Kawasaki disease: evaluating the fluctuation of circulating lymphocytes associated with i.v. immunoglobulin treatment. Fujimoto N; Teramura K; Tanaka T J Dermatol; 2012 Nov; 39(11):957-8. PubMed ID: 22390144 [No Abstract] [Full Text] [Related]
38. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. Wooditch AC; Aronoff SC Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713 [TBL] [Abstract][Full Text] [Related]